Literature DB >> 15198644

Validation of the protective Ostertagia ostertagi ES-thiol antigens with different adjuvantia.

P Geldhof1, I Vercauteren, J Vercruysse, D P Knox, W Van Den Broeck, E Claerebout.   

Abstract

Intramuscular immunization of calves with an excretory-secretory antigen fraction enriched for cysteine proteinase activity (ES-thiol) and QuilA as adjuvant induces a protective immune response against the abomasal nematode Ostertagia ostertagi. The objectives of the present study were to confirm the protective capacity of ES-thiol in combination with QuilA, to test Al(OH)(3) as adjuvant for vaccination against O. ostertagi and to look for correlations between protection and immunological effector responses. Calves(seven animals/group) were vaccinated three times intramuscularly with 100 micro g antigen and/or adjuvant (ES-thiol with QuilA, ES-thiol with Al(OH)(3), QuilA alone and Al(OH)(3) alone) and subsequently challenged with a trickled oral infection of 25 000 infective larvae in total over 25 days. Faecal egg counts in the ES-thiol QuilA group were reduced by 56% during the two-month period of the trial compared to the QuilA control group (P < 0.002). Calves immunized with ES-thiol QuilA had significantly smaller adult worms (P < 0.002) and less eggs/female worm (P < 0.05) compared to the QuilA control group. No differences in egg output, worm counts or parameters of worm fitness were observed in the ES-thiol Al(OH)(3) group compared to the Al(OH)(3) control group. Although the protective immune mechanism against O. ostertagi remains unknown, protection in the ES-thiol QuilA group was associated with high levels of parasite-specific antibodies in the abomasal mucosa.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15198644     DOI: 10.1111/j.0141-9838.2004.00681.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  6 in total

1.  Granule exocytosis of granulysin and granzyme B as a potential key mechanism in vaccine-induced immunity in cattle against the nematode Ostertagia ostertagi.

Authors:  Frederik Van Meulder; Stefanie Van Coppernolle; Jimmy Borloo; Manuela Rinaldi; Robert W Li; Koen Chiers; Wim Van den Broeck; Jozef Vercruysse; Edwin Claerebout; Peter Geldhof
Journal:  Infect Immun       Date:  2013-03-11       Impact factor: 3.441

2.  Host protective ASP-based vaccine against the parasitic nematode Ostertagia ostertagi triggers NK cell activation and mixed IgG1-IgG2 response.

Authors:  Ana González-Hernández; Stefanie Van Coppernolle; Jimmy Borloo; Frederik Van Meulder; Oonagh Paerewijck; Iris Peelaers; Georges Leclercq; Edwin Claerebout; Peter Geldhof
Journal:  Sci Rep       Date:  2016-07-11       Impact factor: 4.379

Review 3.  Recombinant subunit vaccines for soil-transmitted helminths.

Authors:  Jason B Noon; Raffi V Aroian
Journal:  Parasitology       Date:  2017-08-03       Impact factor: 3.234

4.  Niche-specific gene expression in a parasitic nematode; increased expression of immunomodulators in Teladorsagia circumcincta larvae derived from host mucosa.

Authors:  Tom N McNeilly; David Frew; Stewart T G Burgess; Harry Wright; David J Bartley; Yvonne Bartley; Alasdair J Nisbet
Journal:  Sci Rep       Date:  2017-08-03       Impact factor: 4.379

Review 5.  Metazoan Parasite Vaccines: Present Status and Future Prospects.

Authors:  Christian Stutzer; Sabine A Richards; Mariette Ferreira; Samantha Baron; Christine Maritz-Olivier
Journal:  Front Cell Infect Microbiol       Date:  2018-03-13       Impact factor: 5.293

Review 6.  Helminth Vaccines in Ruminants: From Development to Application.

Authors:  Edwin Claerebout; Peter Geldhof
Journal:  Vet Clin North Am Food Anim Pract       Date:  2020-03       Impact factor: 3.357

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.